SpaceX’s blockbuster IPO is coming. This overlooked industrial company will be a big winner

SpaceX is preparing a potential IPO targeting a $1.75 trillion valuation and up to $75 billion in proceeds, with a late-June listing discussed. The article frames Linde as a likely beneficiary, with analysts estimating the IPO could help double its commercial aerospace business to well over $1 billion as launch volumes rise. Linde already supplies gases to 65% to 75% of launches on average and is expanding capacity in Texas and Florida to support SpaceX and the broader space industry.

Analysis

The market is likely underestimating how much a SpaceX re-rating can leak into Linde's order book before any IPO actually prices. The first-order benefit is obvious, but the second-order effect is more interesting: a successful listing should lower the cost of capital across the private-space ecosystem, which can accelerate launch cadence, test activity, and satellite deployment beyond SpaceX alone. That matters because Linde's space revenue behaves more like a tollbooth on industrialization than a one-off launch vendor; higher frequency and more geographically concentrated launch activity should improve plant utilization and pricing discipline, not just volumes.

The key competitive nuance is that this is not a generic aerospace beta trade; it's a concentrated oligopoly with local logistics moats. If SpaceX scales launch frequency as advertised, the relevant question is not whether competitors like APD and Air Liquide participate, but whether anyone can match Linde's near-site supply infrastructure and reliability at the same margin structure. That suggests LIN can compound share even if total industry growth merely normalizes from venture-led exuberance to steady commercial cadence.

The main risk is timing mismatch. The IPO window and the capex/output ramp in Texas and Florida will create a near-term expense drag before the revenue step-up becomes visible, so the stock could digest the narrative for several quarters if investors focus on margin optics rather than optionality. A more serious downside case is that Starship commercialization slips, leaving the current enthusiasm ahead of actual gas consumption; in that scenario, the stocks most exposed to the theme may rerate down while LIN simply reverts to being a high-quality industrial compounder.

The contrarian view is that the move may be too small, not too large. Space is still immaterial to consolidated revenue, which is exactly why this can be mispriced: a path to even low-single-digit mix contribution can still move sentiment if investors begin capitalizing the business at an aerospace-quality multiple. The better trade is to own the most operationally levered enabler rather than the headline IPO, which is untradeable pre-listing and likely to be valued on narrative more than cash flow.

Key Decisions for Investors

• Add to LIN on any post-earnings or post-IPO-volatility pullback over the next 1-3 months; use weakness to build a core long, targeting a 12-month hold with upside from multiple expansion and incremental aerospace mix.
• Pair trade: long LIN / short APD for 6-12 months, expressing higher confidence in execution, nearer-term SpaceX adjacency, and better capital discipline; risk is APD re-rating on its own large project pipeline.
• Buy LIN Jan-2027 call spreads to express multi-quarter launch-cadence upside with defined risk; structure for a 2-3x payout if space revenue visibility improves faster than consensus.
• Avoid chasing FLY into the IPO narrative; if it lists, consider fading early enthusiasm after lock-up-style price discovery rather than paying for a story with limited operating history.
• Monitor AMZN as a secondary beneficiary via Kuiper/Leo capex; if space spending broadens beyond SpaceX, Linde's addressable market expands, but AMZN is the cleaner way to hedge against the thesis being too SpaceX-specific.